High fitness level may decrease risk of colorectal, lung cancers
the ONA take:
According to a new study published online in JAMA Oncology, researchers from the University of Vermont in Burlington, Vermont, have found that men with a high fitness level in midlife may have a lower risk for developing colorectal and lung cancer.
For the study, researchers identified 13,949 men who had a baseline fitness exam where cardiorespiratory fitness (CRF) was assessed and had Medicare data of lung, prostate, and colorectal cancer diagnoses. Results showed that during a mean follow-up of 6.5 years, 1,310 were diagnosed with prostate cancer, 200 with lung cancer, and 181 with colorectal cancer.
The researchers found that those who had a high CRF during midlife had a 55% decreased risk of lung cancer and a 44% decreased risk of colorectal cancer compared with men with low CRF. Those with high CRF did not have a decreased risk for prostate cancer.
Researchers also found that men with high CRF in midline had a 32% decreased risk of cancer death among those who were diagnosed with colorectal, lung, or prostate cancer when they were older compared with men with low CRF.
Men with high CRF in midlife had a 68% decreased risk of cardiovascular disease-associated death compared with men with low CRF who developed cancer.
Men with a high fitness level in midlife may have a lower risk for developing colorectal and lung cancer.
- Study Identifies Factors Associated With Hearing Loss in Polycythemia Vera
- Ezh2 Inhibitors May Offer Cure for Chronic Myelogenous Leukemia
- Ruxolitinib: A Targeted Treatment Option for Patients with Polycythemia Vera
- Incontinence Affects QOL for Survivors of Gynecologic Cancers
- Robotic Surgery Provides Good Outcomes and Survival in Oropharyngeal Cancer
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Sugar and Cancer: Mitigating the Affects of Diet on Cancer
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Tumor Markers (Fact Sheet)
- Implementing a Distress Screening Process for Cancer Patients
- Ruxolitinib Effective as Long-term Treatment Option for Polycythemia Vera
- Definitive IMRT Associated With Shorter Feeding Tube Placement Duration in HNC
- SBRT Improves Overall and Disease-Specific Survival in Stage I NSCLC
- Patients Receiving RT in APBI Facilities Despite Eligibility for Observation
- Prolonged Imatinib Therapy Improves Likelihood of Deeper Molecular Response
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|